Study Stopped
Recruitment difficulties.
Abdominal Pain Disorders Functional in Children: Impact of Hypno-analgesia on the Autonomic Balance
2 other identifiers
observational
8
1 country
1
Brief Summary
Abdominal pain disorders functional (including functional dyspepsia, irritable bowel syndrome, abdominal migraine, functional abdominal pain) is a very common disease in the pediatric population, where classical medical treatment does not always prove effective. This clinical entity has an impact on the individual physiological balance particularly on the autonomic regulation. Studies concerning adults with irritable bowel syndrome, showed significant changes in heart rate variability indices (HRV: heart rate variability). The study of time and frequency domain analysis of HRV allows noninvasive and reproducible assessment of the cardiac sympathetic and parasympathetic tone. The investigators hypothesize that the sympathovagal balance could be altered in children in case of prolonged nociceptive stress as the investigators find it especially in irritable bowel syndrome and functional abdominal pain. In recent years, the control of pediatric pain experienced considerable growth through hypnosis techniques and several studies have shown analgesic efficacy with a beneficial effect in terms of quality of life in children. Our study aims to assess the impact of the hypno-analgesia treatment of Abdominal pain disorders functional on sympathovagal balance. The investigators propose to realize in 7 to 18 years old children with Abdominal pain disorders functional a single center prospective study to highlight after a standardized hypnosis program, changes in the time and frequency domain indices of heart rate variability and clinical or quality of life parameters. The primary endpoint will be the high frequency HF indice. Secondary endpoints will be the other indices of HRV (Ptot, VLF, LF, ratio LF / HF, SDNN, SDANN, pNN50, RMSSD), the Quality of Life Questionnaire values (PedsQL ™ 4.0) a pain scale and the composite score of Francis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2016
CompletedFirst Posted
Study publicly available on registry
July 13, 2016
CompletedStudy Start
First participant enrolled
May 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2019
CompletedNovember 7, 2022
November 1, 2022
1.7 years
June 21, 2016
November 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
high frequency
measured with the holter
One month after the hypno-analgesic therapeutic program
Secondary Outcomes (13)
composite score of Francis
One month after the hypno-analgesic therapeutic program
Pediatric Quality of Life inventory
One month after the hypno-analgesic therapeutic program
a chronic abdominal pain scale
One month after the hypno-analgesic therapeutic program
a severity of functional dyspepsia scale
One month after the hypno-analgesic therapeutic program
a severity of abdominal migraine scale
One month after the hypno-analgesic therapeutic program
- +8 more secondary outcomes
Eligibility Criteria
Indices of autonomic nervous system in a pediatric population with Abdominal pain disorders functional
You may qualify if:
- Parents affiliates or entitled to a social security scheme
- Consent form signed by the holder of parental authority
You may not qualify if:
- Child with pathologies reaching the central nervous system or the brain stem.
- Children with a severe pathology of cardio-respiratory or heart being referred to treatment.
- Children requiring emergency surgery or trauma or septic or inflammatory context.
- Children with psychiatric disorders or mental retardation proven.
- Children who have already used the earlier hypnosis.
- Children not speaking French language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de Saint Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hugues PATURAL, MD PhD
Centre Hospitalier Universitaire de Saint Etienne
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2016
First Posted
July 13, 2016
Study Start
May 31, 2017
Primary Completion
January 31, 2019
Study Completion
May 29, 2019
Last Updated
November 7, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share